This is a preview of subscription content, log in via an institution to check access.
Notes
see PharmacoEconomics & Outcomes News 669 p9; 801085641
References
NICE. Breast cancer treatment not value for money says draft NICE guidance. Media Release : 19 Mar 2013. Available from: URL: http://www.nice.org.uk.
The National Institute for Health and Clinical Excellence. NICE consults on new device for assessing a pregnancy complication which affects thousands of women. Media Release : 19 Mar 2013. Available from: URL: http://www.nice.org.uk.
NICE. NICE recommends drug for idiopathic pulmonary fibrosis in latest draft guidance. Media Release : 21 Mar 2013. Available from: URL: http://www.nice.org.uk.
NICE. NICE says yes to eltrombopag for the treatment of chronic immune (idiopathic) thrombocytopenic purpura in draft guidance. Media Release : 20 Mar 2013. Available from: URL: http://www.nice.org.uk.
NICE. NICE opens consultation on new device to help in placing breathing tubes in people with unexpected difficult airways. Media Release : 21 Mar 2013. Available from: URL: http://www.nice.org.uk.
NICE. NICE draft guidance does not recommend bevacizumab as advanced ovarian cancer treatment - 25 March 2013. Media Release : 25 Mar 2013. Available from: URL: http://www.nice.org.uk.
NICE. NICE consults on new draft recommendations for lung cancer drug. Media Release : 26 Mar 2013. Available from: URL: http://www.nice.org.uk.
NICE. NICE says yes to two treatments for lung infection in adults and children over six with cystic fibrosis. Media Release : 26 Mar 2013. Available from: URL: http://www.nice.org.uk.
NICE. NICE issues final draft guidance on a new kidney cancer drug. Media Release : 27 Mar 2013. Available from: URL: http://www.nice.org.uk.
Rights and permissions
About this article
Cite this article
Recent drug decisions from NICE. PharmacoEcon Outcomes News 675, 10 (2013). https://doi.org/10.1007/s40274-013-0294-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0294-9